المؤلفون: Delpassand ES; Excel Diagnostics and Nuclear Oncology Center, Houston, Texas., Yazdi SM; Excel Diagnostics and Nuclear Oncology Center, Houston, Texas., Ghantoji S; Novartis Pharmaceuticals Corp., East Hanover, New Jersey; and., Nakasato A; Novartis Pharmaceuticals Corp., East Hanover, New Jersey; and., Strickland C; Novartis Pharmaceuticals Corp., East Hanover, New Jersey; and., Nunez R; Excel Diagnostics and Nuclear Oncology Center, Houston, Texas., Shafie A; Excel Diagnostics and Nuclear Oncology Center, Houston, Texas., Cork S; Excel Diagnostics and Nuclear Oncology Center, Houston, Texas., Byrne C; Asclepius Analytics, New York, New York., Tang J; Asclepius Analytics, New York, New York., Patel J; Novartis Pharmaceuticals Corp., East Hanover, New Jersey; and jeetvan.patel@novartis.com.

المصدر: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 May 01; Vol. 65 (5), pp. 746-752. Date of Electronic Publication: 2024 May 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

مواضيع طبية MeSH: Octreotide*/*analogs & derivatives, Neuroendocrine Tumors*/radiotherapy , Octreotide*/therapeutic use , Octreotide*/adverse effects , Organometallic Compounds*/therapeutic use , Organometallic Compounds*/adverse effects , Disease Progression*, Humans ; Male ; Retrospective Studies ; Female ; Middle Aged ; United States ; Aged ; Treatment Outcome ; Adult ; Retreatment ; Safety ; Aged, 80 and over

المؤلفون: Blakkisrud J; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, University of Michigan, Ann Arbor, Michigan; johbla@ous-hf.no.; Department of Physics and Computational Radiology, Oslo University Hospital, Oslo, Norway., Peterson AB; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, University of Michigan, Ann Arbor, Michigan.; Department of Radiation Oncology, Wayne State University, Detroit, Michigan., Wildermann SJ; Department of Nuclear Engineering and Radiologic Science, University of Michigan, Ann Arbor, Michigan., Kingkiner G; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, University of Michigan, Ann Arbor, Michigan., Wong KK; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, University of Michigan, Ann Arbor, Michigan., Wang C; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, University of Michigan, Ann Arbor, Michigan.; Department of Biostatistics, University of Michigan, Ann Arbor, Michigan; and., Frey KA; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, University of Michigan, Ann Arbor, Michigan., Stokke C; Department of Physics and Computational Radiology, Oslo University Hospital, Oslo, Norway.; Department of Physics, University of Oslo, Oslo, Norway., Dewaraja YK; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, University of Michigan, Ann Arbor, Michigan.

المصدر: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 May 01; Vol. 65 (5), pp. 753-760. Date of Electronic Publication: 2024 May 01.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

مواضيع طبية MeSH: Octreotide*/*analogs & derivatives, Octreotide*/therapeutic use , Octreotide*/adverse effects , Organometallic Compounds* , Single Photon Emission Computed Tomography Computed Tomography* , Bone Marrow*/radiation effects , Bone Marrow*/diagnostic imaging , Neuroendocrine Tumors*/radiotherapy , Neuroendocrine Tumors*/diagnostic imaging, Humans ; Male ; Female ; Middle Aged ; Aged ; Adult ; Radiometry ; Radiation Dosage ; Monte Carlo Method ; Hematologic Diseases/diagnostic imaging

المؤلفون: Puranik AD; Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, Maharashtra, India., Dev ID; Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, Maharashtra, India., Rangarajan V; Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, Maharashtra, India., Kulkarni S; Department of Radiodiagnosis, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, Maharashtra, India., Shetty N; Department of Radiodiagnosis, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, Maharashtra, India., Gala K; Department of Radiodiagnosis, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, Maharashtra, India., Sahu A; Department of Radiodiagnosis, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, Maharashtra, India., Bhattacharya K; Department of Radiodiagnosis, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, Maharashtra, India., Dasgupta A; Department of Radiation Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, Maharashtra, India., Chatterjee A; Department of Radiation Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, Maharashtra, India., Gupta T; Department of Radiation Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, Maharashtra, India., Sridhar E; Department of Pathology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, Maharashtra, India., Sahay A; Department of Pathology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, Maharashtra, India., Shetty P; Department of Neurosurgery, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, Maharashtra, India., Singh V; Department of Neurosurgery, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, Maharashtra, India., Moiyadi A; Department of Neurosurgery, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, Maharashtra, India., Menon N; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, Maharashtra, India., Purandare NC; Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, Maharashtra, India., Agrawal A; Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, Maharashtra, India., Shah S; Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, Maharashtra, India., Choudhury S; Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, Maharashtra, India., Ghosh S; Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, Maharashtra, India., Jha AK; Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, Maharashtra, India.

المصدر: Neurology India [Neurol India] 2024 Mar 01; Vol. 72 (2), pp. 278-284. Date of Electronic Publication: 2024 Apr 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Medknow Publications Country of Publication: India NLM ID: 0042005 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1998-4022 (Electronic) Linking ISSN: 00283886 NLM ISO Abbreviation: Neurol India Subsets: MEDLINE

مواضيع طبية MeSH: Octreotide*/*analogs & derivatives, Meningioma*/radiotherapy , Meningioma*/diagnostic imaging , Meningeal Neoplasms*/radiotherapy , Meningeal Neoplasms*/diagnostic imaging , Octreotide*/therapeutic use , Octreotide*/administration & dosage, Humans ; Female ; Male ; Middle Aged ; Adult ; Organometallic Compounds/therapeutic use ; Aged ; Treatment Outcome ; Radiopharmaceuticals/therapeutic use ; Receptors, Peptide ; Tertiary Care Centers ; Disease Progression

المؤلفون: Mansouri Z; Division of Nuclear Medicine and Molecular Imaging, Department of Medical Imaging, Geneva University Hospital, CH-1211, Geneva, Switzerland., Salimi Y; Division of Nuclear Medicine and Molecular Imaging, Department of Medical Imaging, Geneva University Hospital, CH-1211, Geneva, Switzerland., Akhavanallaf A; Division of Nuclear Medicine and Molecular Imaging, Department of Medical Imaging, Geneva University Hospital, CH-1211, Geneva, Switzerland., Shiri I; Division of Nuclear Medicine and Molecular Imaging, Department of Medical Imaging, Geneva University Hospital, CH-1211, Geneva, Switzerland., Teixeira EPA; Division of Nuclear Medicine and Molecular Imaging, Department of Medical Imaging, Geneva University Hospital, CH-1211, Geneva, Switzerland., Hou X; Department of Radiology, University of British Columbia, Vancouver, BC, Canada., Beauregard JM; Cancer Research Centre and Department of Radiology and Nuclear Medicine, Université Laval, Quebec City, QC, Canada., Rahmim A; Department of Radiology, University of British Columbia, Vancouver, BC, Canada., Zaidi H; Division of Nuclear Medicine and Molecular Imaging, Department of Medical Imaging, Geneva University Hospital, CH-1211, Geneva, Switzerland. habib.zaidi@hcuge.ch.; Department of Nuclear Medicine, University Medical Center Groningen, University of Groningen, 9700 RB, Groningen, Netherlands. habib.zaidi@hcuge.ch.; Department of Nuclear Medicine, University of Southern Denmark, DK-500, Odense, Denmark. habib.zaidi@hcuge.ch.; University Research and Innovation Center, Óbuda University, Budapest, Hungary. habib.zaidi@hcuge.ch.

المصدر: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 May; Vol. 51 (6), pp. 1516-1529. Date of Electronic Publication: 2024 Jan 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE

مواضيع طبية MeSH: Octreotide*/*analogs & derivatives, Octreotide*/therapeutic use , Organometallic Compounds*/therapeutic use , Single Photon Emission Computed Tomography Computed Tomography*/methods , Radiometry*/methods , Radiopharmaceuticals*/therapeutic use, Humans ; Precision Medicine/methods ; Deep Learning ; Male ; Female ; Monte Carlo Method ; Image Processing, Computer-Assisted/methods ; Neuroendocrine Tumors/radiotherapy ; Neuroendocrine Tumors/diagnostic imaging

المؤلفون: Donzé C; Nuclear medicine department, Institut régional du Cancer de Montpellier (ICM), Univ. Montpellier, Montpellier, France., Rubira L; Nuclear medicine department, Institut régional du Cancer de Montpellier (ICM), Univ. Montpellier, Montpellier, France., Santoro L; Nuclear medicine department, Institut régional du Cancer de Montpellier (ICM), Univ. Montpellier, Montpellier, France., Viarasakd M; Nuclear medicine department, Institut régional du Cancer de Montpellier (ICM), Univ. Montpellier, Montpellier, France., Kotzki PO; Nuclear medicine department, Institut régional du Cancer de Montpellier (ICM), Univ. Montpellier, Montpellier, France.; Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Univ. Montpellier, Institut régional du Cancer de Montpellier (ICM), Montpellier, France., Deshayes E; Nuclear medicine department, Institut régional du Cancer de Montpellier (ICM), Univ. Montpellier, Montpellier, France.; Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Univ. Montpellier, Institut régional du Cancer de Montpellier (ICM), Montpellier, France., Fersing C; Nuclear medicine department, Institut régional du Cancer de Montpellier (ICM), Univ. Montpellier, Montpellier, France cyril.fersing@icm.unicancer.fr.; IBMM, Univ Montpellier, CNRS, ENSCM, Montpellier, France.

المصدر: European journal of hospital pharmacy : science and practice [Eur J Hosp Pharm] 2024 Apr 23; Vol. 31 (3), pp. 207-211. Date of Electronic Publication: 2024 Apr 23.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101578294 Publication Model: Electronic Cited Medium: Print ISSN: 2047-9956 (Print) Linking ISSN: 20479956 NLM ISO Abbreviation: Eur J Hosp Pharm Subsets: MEDLINE

مواضيع طبية MeSH: Octreotide*/*analogs & derivatives, Octreotide*/administration & dosage , Infusion Pumps*/standards , Organometallic Compounds*/administration & dosage , Occupational Exposure*/prevention & control , Neuroendocrine Tumors*/radiotherapy, Humans ; Radiopharmaceuticals/administration & dosage ; Infusions, Intravenous ; Radiation Exposure/prevention & control

المؤلفون: Remba-Shapiro I; Neuroendocrine Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: iremba@mgh.harvard.edu., Nachtigall LB; Neuroendocrine Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: lnachtigall@partners.org.

المصدر: Best practice & research. Clinical endocrinology & metabolism [Best Pract Res Clin Endocrinol Metab] 2024 Jul; Vol. 38 (4), pp. 101888. Date of Electronic Publication: 2024 Feb 22.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101120682 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1594 (Electronic) Linking ISSN: 1521690X NLM ISO Abbreviation: Best Pract Res Clin Endocrinol Metab Subsets: MEDLINE

مواضيع طبية MeSH: Octreotide*/administration & dosage , Octreotide*/therapeutic use , Octreotide*/adverse effects , Acromegaly*/drug therapy , Antineoplastic Agents, Hormonal*/adverse effects , Antineoplastic Agents, Hormonal*/administration & dosage , Antineoplastic Agents, Hormonal*/therapeutic use, Humans ; Administration, Oral ; Human Growth Hormone/administration & dosage ; Adenoma/drug therapy ; Adenoma/complications ; Growth Hormone-Secreting Pituitary Adenoma/drug therapy ; Growth Hormone-Secreting Pituitary Adenoma/complications

المؤلفون: Fleseriu M; Departments of Medicine and Neurological Surgery, Pituitary Center, Oregon Health & Science University, Portland, OR, USA., Nachtigall LB; Neuroendocrine Clinical Center, Massachusetts General Hospital Neuroendocrine and Pituitary Center, Chestnut Hill, MA, USA., Samson SL; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Department of Neurologic Surgery, Mayo Clinic, Jacksonville, FL, USA., Melmed S; Pituitary Center, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

المصدر: Expert review of endocrinology & metabolism [Expert Rev Endocrinol Metab] 2024 Jul; Vol. 19 (4), pp. 367-375. Date of Electronic Publication: 2024 Jun 06.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101278293 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8417 (Electronic) Linking ISSN: 17446651 NLM ISO Abbreviation: Expert Rev Endocrinol Metab Subsets: MEDLINE

مواضيع طبية MeSH: Acromegaly*/drug therapy , Octreotide*/administration & dosage , Octreotide*/therapeutic use , Octreotide*/adverse effects , Antineoplastic Agents, Hormonal*/administration & dosage , Antineoplastic Agents, Hormonal*/therapeutic use , Antineoplastic Agents, Hormonal*/adverse effects , Quality of Life*, Humans ; Administration, Oral ; Capsules ; Adenoma/drug therapy ; Growth Hormone-Secreting Pituitary Adenoma/drug therapy ; Clinical Trials as Topic ; Treatment Outcome

المؤلفون: Steinhelfer L; Department of Radiology, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany; lisa.steinhelfer@tum.de rbraren@tum.de., Jungmann F; Department of Radiology, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany., Endrös L; Department of Radiology, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany., Wenzel P; Medical Clinic and Polyclinic II, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany., Haller B; Institute of AI and Informatics in Medicine, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany., Nickel M; Institute of AI and Informatics in Medicine, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany., Haneder E; Department of Radiology, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany., Geisler F; Medical Clinic and Polyclinic II, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany., Götze K; Medical Clinic and Polyclinic III, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany., von Werder A; Medical Clinic and Polyclinic II, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany., Eiber M; Department of Nuclear Medicine, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany; and.; German Cancer Consortium, a Partnership Between DKFZ and School of Medicine, Technical University of Munich, Munich, Germany., Makowski MR; Department of Radiology, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany., Braren R; Department of Radiology, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany; lisa.steinhelfer@tum.de rbraren@tum.de.; German Cancer Consortium, a Partnership Between DKFZ and School of Medicine, Technical University of Munich, Munich, Germany., Lohöfer F; Department of Radiology, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.

المصدر: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Aug 01; Vol. 65 (8), pp. 1244-1249. Date of Electronic Publication: 2024 Aug 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

مواضيع طبية MeSH: Leukopenia*/etiology , Spleen*/diagnostic imaging , Spleen*/radiation effects , Octreotide*/analogs & derivatives , Octreotide*/therapeutic use , Octreotide*/adverse effects , Neuroendocrine Tumors*/radiotherapy , Neuroendocrine Tumors*/diagnostic imaging , Receptors, Peptide*/metabolism , Organometallic Compounds*/adverse effects , Organometallic Compounds*/therapeutic use, Humans ; Female ; Male ; Middle Aged ; Retrospective Studies ; Aged ; Organ Size ; Adult ; Biomarkers ; Aged, 80 and over

المؤلفون: Larive T; Department of Nuclear Medicine, CHRU Nancy, Université de Lorraine, Nancy, France.; Nancyclotep Imaging Platform, CHRU Nancy, Université de Lorraine, Nancy, France., Boursier C; Department of Nuclear Medicine, CHRU Nancy, Université de Lorraine, Nancy, France.; Nancyclotep Imaging Platform, CHRU Nancy, Université de Lorraine, Nancy, France.; UMR 1254, INSERM, Université de Lorraine, Nancy, France., Claudin M; Department of Nuclear Medicine, CHRU Nancy, Université de Lorraine, Nancy, France.; Nancyclotep Imaging Platform, CHRU Nancy, Université de Lorraine, Nancy, France., Varlot J; Department of Cardiology, CHRU Nancy, Nancy, France., Filippetti L; Department of Cardiology, CHRU Nancy, Nancy, France., Huttin O; Department of Cardiology, CHRU Nancy, Nancy, France.; UMR 1116, INSERM, Université de Lorraine, Nancy, France., Roch V; Nancyclotep Imaging Platform, CHRU Nancy, Université de Lorraine, Nancy, France., Imbert L; Department of Nuclear Medicine, CHRU Nancy, Université de Lorraine, Nancy, France.; Nancyclotep Imaging Platform, CHRU Nancy, Université de Lorraine, Nancy, France.; UMR 1254, INSERM, Université de Lorraine, Nancy, France., Doyen M; UMR 1254, INSERM, Université de Lorraine, Nancy, France.; Université de Lorraine, Nancy, France., Lambert A; Department of Medical Oncology, Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France., Mandry D; UMR 1254, INSERM, Université de Lorraine, Nancy, France.; Department of Radiology, CHRU Nancy, Université de Lorraine, Nancy, France., Lamiral Z; CIC 1433, INSERM, CHRU Nancy, Nancy, France., Chevalier E; Department of Nuclear Medicine, CHRU Nancy, Université de Lorraine, Nancy, France.; Nancyclotep Imaging Platform, CHRU Nancy, Université de Lorraine, Nancy, France., Marie PY; Department of Nuclear Medicine, CHRU Nancy, Université de Lorraine, Nancy, France; py.marie@chru-nancy.fr.; Nancyclotep Imaging Platform, CHRU Nancy, Université de Lorraine, Nancy, France.; UMR 1254, INSERM, Université de Lorraine, Nancy, France.

المصدر: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Aug 01; Vol. 65 (8), pp. 1279-1285. Date of Electronic Publication: 2024 Aug 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

مواضيع طبية MeSH: Myocarditis*/diagnostic imaging , Myocarditis*/metabolism , Myocardium*/metabolism , Somatostatin*/analogs & derivatives , Somatostatin*/metabolism , Positron-Emission Tomography* , Octreotide*/analogs & derivatives , Octreotide*/metabolism , Octreotide*/pharmacokinetics, Humans ; Male ; Female ; Middle Aged ; Adult ; Acute Disease ; Diagnosis, Differential ; Aged ; Heart/diagnostic imaging ; Organometallic Compounds/pharmacokinetics ; Organometallic Compounds/metabolism ; Biological Transport ; Retrospective Studies ; Radiopharmaceuticals/pharmacokinetics ; Neoplasms/diagnostic imaging ; Neoplasms/metabolism

المؤلفون: De Silva MK; From the Department of Medical Oncology, Royal North Shore Hospital, Sydney, New South Wales, Australia., Chan DLH, Bernard EJ, Conner AJ; From the Department of Medical Oncology, Royal North Shore Hospital, Sydney, New South Wales, Australia., Mascall SL; From the Department of Medical Oncology, Royal North Shore Hospital, Sydney, New South Wales, Australia., Bailey DL, Roach PJ, Clarke SJ, Diakos CI, Pavlakis N, Schembri G

المصدر: Pancreas [Pancreas] 2024 Aug 01; Vol. 53 (7), pp. e560-e565.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8608542 Publication Model: Print Cited Medium: Internet ISSN: 1536-4828 (Electronic) Linking ISSN: 08853177 NLM ISO Abbreviation: Pancreas Subsets: MEDLINE

مواضيع طبية MeSH: Neuroendocrine Tumors*/pathology , Neuroendocrine Tumors*/radiotherapy , Neuroendocrine Tumors*/diagnostic imaging , Neuroendocrine Tumors*/metabolism , Neuroendocrine Tumors*/mortality , Fluorodeoxyglucose F18* , Octreotide*/analogs & derivatives , Octreotide*/therapeutic use , Radiopharmaceuticals* , Positron-Emission Tomography*/methods , Tumor Burden* , Organometallic Compounds*/therapeutic use, Humans ; Male ; Middle Aged ; Female ; Retrospective Studies ; Aged ; Prognosis ; Adult ; Receptors, Peptide/metabolism ; Glycolysis ; Aged, 80 and over ; Pancreatic Neoplasms/pathology ; Pancreatic Neoplasms/radiotherapy ; Pancreatic Neoplasms/diagnostic imaging ; Pancreatic Neoplasms/mortality ; Progression-Free Survival ; Treatment Outcome